SIQNATURE host response test

Genexpressionstest für Sepsis

Sepsis oder SIRS? - Gewinnen Sie Zeit in kritischen Situationen

Wenn Patienten Symptome einer SIRS oder Sepsis zeigen kann das den Arzt vor signifikante Herausforderungen stellen.

Konventionelle klinische Diagnostika können meist keine klare Antwort geben um eine Entscheidung innerhalb der kritischen Zeit zu treffen. 

SIRS-Lab hat einen vollkommen neuen Biomarker basierten Ansatz für Sepsis entwickelt. Der transkriptomische Test SIQNATURE soll Ärzten spezifische Informationen über eine bevorstehende Sepsis liefern.

Verschiedene Biomarker in einem Score

Der Test befindet sich derzeit in der Entwicklung

SIRS-Lab begrüßt Anfragen zu Entwicklungskooperationen von Unternehmen aus Diagnostik und Technologie.
Kontact Business Development »

References
Free Presentation

Watch a presentation on transcriptomic biomarkers held at the 2009 "sepsis update" in Weimar/Germany by Prof. M. Bauer »

"Best Poster Award - SEPSIS 2008 An international symposium"  

Experts at the International Sepsis Forum 2008 (ISF) awarded SIQNATURE as highly innovative concept. 

A novel multiplex qPCR assay for the early prediction of sepsis in critical ill patients presenting signs of shock and organ dysfunction
Bauer M, Möller E, Russwurm S, Reinhart K

Your opinion?
You are a clinical expert and like to get insight in our development projects in sepsis identification? Please fill in the short questionnaire and help us to develop the diagnostics you need. Get our free newsletter to stay informed about new developments in the field.
Fragebogen
1. In the daily clinical work with your patients, is reliable and quick "Sepsis Identification" a problem? If yes is it...


2. What is your standard diagnostic method to confirm a suspected sepsis?


3. Which diagnostic gaps and challenges do you see related to sepsis identification?


4. How would you rank sepsis identification and sepsis monitoring in terms of importance and/or difficulty in your daily clinical routine and why?
- Importance


- Difficulty


5. Which improvements do you require in the field of sepsis identification?


6. Assuming, you would have access to a rapid, reliable and easy-to-use sepsis identification and sepsis monitoring test - for what indications and patient cases would you routinely use such a test?


7. If you would solve the current gaps in sepsis identification and sepsis monitoring diagnostics, how would your patients profit from it?


8. If performance of sepsis identification and sepsis monitoring diagnostics would significantly improve, what would be the value for the health economic system?


Thank you for your participation.